Reports

As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Psoriatic Arthritis Therapeutics Market: By Drug Class: TNF Inhibitors, Interleukin Inhibitors, PDE4 Inhibitors; By Route of Administration: Oral, Parenteral, Topical; By Distribution Channel; Regional Analysis; Historical Market and Forecast (2016-2026); SWOT Analysis; Competitive Landscape; Industry Events and Developments

Global Psoriatic Arthritis Therapeutics Market Outlook

The global psoriatic arthritis therapeutics market is projected to grow at a CAGR of 6.5% in the forecast period of 2021-2026.

 

The market growth is being driven by the growing health awareness among the consumers. North America is leading the regional market in the industry as a result of the increasing demand for the product, especially, from the United States.

 

Global Psoriatic Arthritis Therapeutics Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Properties and Applications

Psoriatic arthritis is a chronic disease associated with psoriasis. The condition needs timely treatment, the absence of which may lead to irreversible joint damage.

The psoriatic arthritis therapeutics market can be broadly categorised based on drug class, route of administration, and distribution channel.

 

Global Psoriatic Arthritis Therapeutics Market By Distribution Channel

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Based on the drug class, the industry can be segmented into:

  • TNF Inhibitors
  • Interleukin Inhibitors
  • PDE4 Inhibitors
  • Others

Based on the route of administration, the industry can be divided into:

  • Oral
  • Parenteral
  • Topical

Based on the distribution channel, the market can be divided into:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

The EMR report looks into the regional markets of psoriatic arthritis therapeutics like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.

 

Global Psoriatic Arthritis Therapeutics Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Analysis

The global psoriatic arthritis therapeutics market is being driven by the launch of new products, the increasing prevalence of psoriatic arthritis, and the growing consumer awareness regarding their health. Interleukin inhibitors are leading the drug class segment due to the rising emergence of biosimilars. North America, along with Europe, held more than half the overall market revenue in 2020 owing to rising commercial sales of products in the United States, the presence of key players, initiatives undertaken by the governments, the enactment of favourable policies, and the increasing incidence of psoriatic arthritis. The Asia Pacific is estimated to witness the fastest growth in the forecast period as a result of the increasing disposable income of consumers, improvement in healthcare facilities, economic growth, and the rising adoption of biosimilars in emerging markets such as China, India, and South Korea.

 

Competitive Landscape

The report presents a detailed analysis of the following key players in the global psoriatic arthritis therapeutics market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • AbbVie, Inc. (NYSE: ABBV)
  • Janssen Global Services LLC (Johnson & Johnson)
  • Novartis AG 
  • Amgen, Inc. 
  • Celgene Corporation 
  • Pfizer, Inc. 
  • Eli Lilly and Company 
  • UCB SA. 
  • Biogen Inc. 
  • Bristol-Myers Squibb Company

The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

Key Questions Answered in the Market Report

  • How has the global psoriatic arthritis therapeutics market performed in the previous years (2016-2020)?
  • What is the forecast assessment of the market for 2021-2026?
  • What are the major drivers in the historical (2016-2020) and forecast (2021-2026) periods?
  • What are the major constraints in the historical (2016-2020) and forecast (2021-2026) periods?
  • What are the major demand indicators of the global market?
  • Who are the key manufacturers in the global market?
  • What is the degree of competition in the global market?
  • What are the major events and developments taking place within the global industry?

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
    1.1    Objectives of the Study
        1.1.1    Research Objective
        1.1.2    Key findings of the Study
2    Research Methodology
    2.1    Data Extraction
    2.2    Data Corroboration
    2.3    Market Structure
    2.4    Inference Data 
3    Executive Summary
    3.1    Market Overview
    3.2    Market Analysis
4    Global Psoriatic Arthritis Therapeutics Market Analysis
    4.1    Global Psoriatic Arthritis Therapeutics Historical Market (2016-2020) & Forecast (2021-2026)
    4.2    Global Psoriatic Arthritis Therapeutics Market Breakup by Drug Class
        4.2.1    TNF Inhibitors
        4.2.2    Interleukin Inhibitors
        4.2.3    PDE4 Inhibitors
        4.2.4    Others
    4.3     Global Psoriatic Arthritis Therapeutics Market Breakup by Drug Class: Historical Market (2016-2020) & Forecast (2021-2026)
        4.3.1    TNF Inhibitors
        4.3.2    Interleukin Inhibitors
        4.3.3    PDE4 Inhibitors
        4.3.4    Others
    4.4    Global Psoriatic Arthritis Therapeutics Market Breakup by Route of Administration  
        4.4.1    Oral
        4.4.2    Parenteral
        4.4.3    Topical
    4.5    Global Psoriatic Arthritis Therapeutics Market Breakup by Route of Administration: Historical Market (2016-2020) & Forecast (2021-2026)
        4.5.1    Oral
        4.5.2    Parenteral
        4.5.3    Topical
    4.6    Global Psoriatic Arthritis Therapeutics Market Breakup by Distribution Channel
        4.6.1    Hospital Pharmacies
        4.6.2    Retail Pharmacies
        4.6.3    Online Pharmacies
    4.7    Global Psoriatic Arthritis Therapeutics Market Breakup by Distribution Channel: Historical Market (2016-2020) & Forecast (2021-2026)
        4.7.1    Hospital Pharmacies
        4.7.2    Retail Pharmacies
        4.7.3    Online Pharmacies
    4.8    Global Psoriatic Arthritis Therapeutics Market Breakup by Region
        4.8.1    North America
            4.8.1.1    United States of America
            4.8.1.2    Canada
        4.8.2    Europe
            4.8.2.1    Germany
            4.8.2.2    United Kingdom
            4.8.2.3    France
            4.8.2.4    Italy
            4.8.2.5    Others
        4.8.3    Asia Pacific
            4.8.3.1    China
            4.8.3.2    Japan
            4.8.3.3    India
            4.8.3.4    ASEAN
            4.8.3.5    Others
        4.8.4    Latin America
            4.8.4.1    Brazil
            4.8.4.2    Argentina
            4.8.4.3    Mexico
            4.8.4.4    Others
        4.8.5    Middle East & Africa
            4.8.5.1    Saudi Arabia
            4.8.5.2    United Arab Emirates
            4.8.5.3    Nigeria
            4.8.5.4    South Africa
            4.8.5.5    Others
    4.9     Global Psoriatic Arthritis Therapeutics Market Breakup by Region: Historical Market (2016-2020) & Forecast (2021-2026)
        4.9.1    North America
            4.9.1.1    United States of America
            4.9.1.2    Canada
        4.9.2    Europe
            4.9.2.1    Germany
            4.9.2.2    United Kingdom
            4.9.2.3    France
            4.9.2.4    Italy
            4.9.2.5    Others
        4.9.3    Asia Pacific
            4.9.3.1    China
            4.9.3.2    Japan
            4.9.3.3    India
            4.9.3.4    ASEAN
            4.9.3.5    Others
        4.9.4    Latin America
            4.9.4.1    Brazil
            4.9.4.2    Argentina
            4.9.4.3    Mexico
            4.9.4.4    Others
        4.9.5    Middle East & Africa
            4.9.5.1    Saudi Arabia
            4.9.5.2    United Arab Emirates
            4.9.5.3    Nigeria
            4.9.5.4    South Africa
            4.9.5.5    Others
5    SWOT Analysis
    5.1    Overview
    5.2    Strengths
    5.3    Weaknesses
    5.4    Opportunities
    5.5    Threats
6    Porter’s Five Forces Analysis
    6.1    Overview
    6.2    Buyer’s Power
    6.3    Supplier’s Power
    6.4    New Entrants
    6.5    Degree of Rivalry
    6.6    Substitutes
7    Competitive Landscape & Supplier Analysis   
    7.1    AbbVie, Inc. (NYSE: ABBV)
        7.1.1    Company Overview
        7.1.2    Financial Analysis
    7.2    Janssen Global Services LLC (Johnson & Johnson) 
        7.2.1    Company Overview
        7.2.2    Financial Analysis
    7.3    Novartis AG (SWX: NOVN)
        7.3.1    Company Overview
        7.3.2    Financial Analysis
    7.4    Amgen, Inc. (NASDAQ: AMGN)
        7.4.1    Company Overview
        7.4.2    Financial Analysis
    7.5    Celgene Corporation (NASDAQ: CELG)
        7.5.1    Company Overview
        7.5.2    Financial Analysis
    7.6    Pfizer, Inc. (NYSE: PFE)
        7.6.1    Company Overview
        7.6.2    Financial Analysis
    7.7    Eli Lilly and Company (NYSE: LLY)
        7.7.1    Company Overview
        7.7.2    Financial Analysis
    7.8    UCB SA. (EBR: UCB)
        7.8.1    Company Overview
        7.8.2    Financial Analysis
    7.9    Biogen Inc. (NASDAQ: BIIB)
        7.9.1    Company Overview
        7.9.2    Financial Analysis
    7.10    Bristol-Myers Squibb Company (NYSE: BMY)
        7.10.1    Company Overview
        7.10.2    Financial Analysis
8    Industry Events and Developments

Purchase Full Report

Mini Report

$ 1999     $1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 3199     $2499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$ 4199     $3499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 5199     $4499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports

Global Oxygen Therapy Market Report and Forecast 2021-2026


Global Topical Pain Relief Market Report and Forecast 2021-2026


Global Aortic Valve Replacement Market Report and Forecast 2021-2026


Global Radiation Oncology Market Report and Forecast 2021-2026


Global Noninvasive Neuromodulation Market Report and Forecast 2021-2026


NEWSLETTER